LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Varlilumab Is Safe and Active in Patients with Advanced Solid Tumors.

Photo from archive.org

Varlilumab activates the CD27 pathway in T cells to promote antitumor activity in solid tumors. Click to show full abstract

Varlilumab activates the CD27 pathway in T cells to promote antitumor activity in solid tumors.

Keywords: solid tumors; advanced solid; patients advanced; active patients; safe active; varlilumab safe

Journal Title: Cancer discovery
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.